CORRESP Filing
MEDICINOVA INC
Date: Dec. 9, 2025 · CIK: 0001226616 · Accession: 0001193125-25-312838
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291967
Letter
Re: Acceleration Request of MediciNova, Inc. Registration Statement on Form S-3 Filed December 5, 2025 (File No. 333-291967) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Thursday, December 11, 2025, or as soon thereafter as practicable. The Company hereby authorizes Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060.
December 9, 2025 VIA EDGAR Division of Corporation Finance Office of Life Science United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory
Very truly yours,
/s/ Yuichi Iwaki
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 9, 2025 VIA EDGAR Division of Corporation Finance Office of Life Science United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: Acceleration Request of MediciNova, Inc. Registration Statement on Form S-3 Filed December 5, 2025 (File No. 333-291967) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Thursday, December 11, 2025, or as soon thereafter as practicable. The Company hereby authorizes Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060. Very truly yours, /s/ Yuichi Iwaki Yuichi Iwaki President and Chief Executive Officer